About: Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 25 March 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2019 (uk) article scientifique publié en 2019 (fr) im März 2019 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2019 (ast) scientific article published on 25 March 2019 (en)
publication date	wds:Q64054148-368F9CB2-8CA8-426D-93D6-1FD3B39B91A4
publication date	2019-03-25 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64054148-70034047-8FC9-487F-A790-FED863AA7D26
language of work or name	English
exact match	wds:Q64054148-F195E143-B9BD-47EA-B32E-0BF04B67DDC6
exact match	https://scigraph.springernature.com/pub.10.1186/s12882-019-1292-3
cites work	wds:Q64054148-0077F440-BD00-4D16-9171-A46A3A5E7766 wds:Q64054148-01EF6ED6-FA60-4F5C-9589-202B313038DC wds:Q64054148-05F19D29-8AD5-4489-A0DC-1CF1A55E18C6 wds:Q64054148-08DC26D4-2811-44CD-8E94-1B31F4CBB160 wds:Q64054148-116D47EB-8376-43F9-B9E2-269427EE590E wds:Q64054148-130E0613-5409-4BD6-87B4-E67481A7C5D5 wds:Q64054148-233F5998-7347-420C-B1F6-0EDEB5B3A6FE wds:Q64054148-282EC95E-4A16-4858-8701-CB1106EF0FAE wds:Q64054148-3822D34F-4B56-4492-8D1F-C1B80BA2991A wds:Q64054148-3DCF939A-771D-4EEA-A89C-00BC4BE43FD9 wds:Q64054148-43B7D0D1-4707-4615-8620-5A650C7CF43C wds:Q64054148-45472FA5-48C1-4462-8E9C-BECE90291330 wds:Q64054148-47767F77-7107-46C3-9928-9D0067D06968 wds:Q64054148-4D7C9E56-4BF1-49C6-861D-09721A7C709E wds:Q64054148-542F9727-B47C-416B-9C06-7AC8F70C8BC5 wds:Q64054148-56617A10-DDD4-4096-9928-7370A47D5BF9 wds:Q64054148-56F78EE9-01B4-4B6F-903A-311967845180 wds:Q64054148-5773B4B1-4FDA-431F-92DE-1BF5D8910D35 wds:Q64054148-611E6775-37AA-485F-88C3-2F3E12377F29 wds:Q64054148-712679B6-8114-4DF3-845C-F3E33BC73027 wds:Q64054148-75EF308A-8A6E-4653-9C60-1FEFDCC926E5 wds:Q64054148-796FF0DE-4053-4C15-99BE-06AA3A3D9F0F wds:Q64054148-7D0FA879-2485-4A44-BF71-004AE9D6072A wds:Q64054148-86FD42E9-B122-4087-8DA5-82271C45701A wds:Q64054148-8E56663E-7E76-4604-ADC8-E01D7238D8C8 wds:Q64054148-9298E3C3-98E3-4E32-8B1A-F86F05B0CB02 wds:Q64054148-995BF9A7-7F58-4E19-9A21-A6EFAC7A5A9F wds:Q64054148-9B554423-1C75-4E68-BB99-D676491AF2C8 wds:Q64054148-A448B147-753D-44E3-8805-AC153EC27152 wds:Q64054148-A84109AA-AFBE-483C-AC87-9ADD53C606EA wds:Q64054148-AD0911DF-136E-4365-853F-9E15E572BDC0 wds:Q64054148-AF2464B7-7943-4F50-AA8E-E6F05AACA5B4 wds:Q64054148-B994BDDD-900E-4BD2-8229-E56045DA928F wds:Q64054148-B9CBFDD7-5DD0-473B-BB04-C1FCD426B086 wds:Q64054148-C29059E7-0295-40C8-8063-CB737E857EE2 wds:Q64054148-C6F26F31-D911-4211-A5E6-2634A80663C5 wds:Q64054148-C8A99019-824D-45C0-A60F-ECD966C1BF6B wds:Q64054148-CE53F5E3-DE92-4270-BBE3-AD383DF9CD8E wds:Q64054148-DE96A052-A373-4E21-A338-F2C7103560B2 wds:Q64054148-E78849F3-C7F2-40F2-B513-CCD8E6C3B6C8 wds:Q64054148-E98965F8-2C11-4773-81C8-57E290B92559 wds:Q64054148-EE93F655-948F-492D-847D-6C04D5FE0234 wds:Q64054148-F214B853-85C1-4D9F-8E41-1D4D5C2819EB
cites work	Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Predictors of autosomal dominant polycystic kidney disease progression Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease Renal structure and hypertension in autosomal dominant polycystic kidney disease Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial A new equation to estimate glomerular filtration rate Cardiorenal end points in a trial of aliskiren for type 2 diabetes Combined angiotensin inhibition for the treatment of diabetic nephropathy The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group Recent advances in understanding integrative control of potassium homeostasis The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014) Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methods Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease Angiotensin blockade in late autosomal dominant polycystic kidney disease Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials Blood pressure in early autosomal dominant polycystic kidney disease Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron The origin and the clinical significance of urinary angiotensinogen in proteinuric IgA nephropathy patients. On the Origin of Urinary Renin: A Translational Approach Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis The utility of the transtubular potassium gradient in the evaluation of hyperkalemia Urine electrolytes and osmolality: when and how to use them Urinary Sodium and Potassium Excretion and CKD Progression Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients. On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention Development of a test to evaluate the transtubular potassium concentration gradient in the cortical collecting duct in vivo Urinary Renin-Angiotensin Markers in Polycystic Kidney Disease 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association T Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.
author name string	wds:Q64054148-76B594BD-C7AC-4A2C-8ED1-F3118BE2987D

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software